A novel pathway mediating the development of chronic orofacial neuropathic pain

介导慢性口面部神经病理性疼痛发展的新途径

基本信息

  • 批准号:
    8705625
  • 负责人:
  • 金额:
    $ 12.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-07 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic orofacial pain is a common clinical syndrome lacking specific and effective therapeutic agents due to the fact that cellular mechanisms of chronic orofacial pain are poorly understood. Based on our preliminary data from a trigeminal nerve injury model and in non-orofacial pain models, we hypothesize that trigeminal nerve injury induced thrombospondin-4 (TSP4) expression in trigeminal ganglia (TG) and associated brainstem/upper cervical spinal cord (Vc/C2) that causes sensory neuron hyperexcitability, and abnormal synaptogenesis in the trigeminal complex in the spinal cord. These changes underlie the transition from trigeminal nerve injury to chronic pain development. In this proposal, we plan to identify the critical domain(s) of TSP4 in mediating behavioral hypersensitivity and spinal neuron hyperexcitability. Viral driven TSP4 expression in TG or Vc/C2, respectively, will be used to identify the site of the TSP4's action in chronic pain processing. We will perform confocal and electron microscopy to determine the extent of abnormal synaptogenesis in the nerve injury models. In addition, the influence of descending modulatory pathways and voltage-gated-calcium channels on TSP4-mediated behavioral hypersensitivity and dorsal horn neuron hyperexcitability will be studies using respective drugs. The influence of TSP4 on sensory neuron excitability, calcium channel activities, and intracellular calcium signaling will be studied in isolated neurons or intact TG from nerve injury models, or after TSP4 treatment. To determine if TSP4 induces behavioral hypersensitivity and dorsal horn neuron hyperexcitability through its interactions with its receptor, the calcium channel alpha-2-delta-1 subunit (Cava2d1), in a sensory neuron specific manner, Cava2d1 conditional knockout mice with selective deletion of Cava2d1 in subpopulation of sensory neurons will be used for these studies. The final goal of the proposed studies is to identify the peripheral and/or central mechanisms underlying TSP4-mediated transition to chronic pain states after trigeminal nerve injury.
描述(申请人提供):慢性口面部疼痛是一种常见的临床综合征,由于人们对慢性口面部疼痛的细胞机制知之甚少,缺乏特异性和有效的治疗药物。根据我们在三叉神经损伤模型和非口面疼痛模型中的初步数据,我们假设三叉神经损伤诱导三叉神经节(TG)和相关脑干/上颈脊髓(Vc/C2)表达血小板反应蛋白-4(TSP4),从而导致感觉神经元过度兴奋以及三叉神经突触发生异常 复杂的脊髓。这些变化是从三叉神经损伤向慢性疼痛发展转变的基础。在本提案中,我们计划确定 TSP4 在介导行为超敏反应和脊髓神经元过度兴奋中的关键域。病毒驱动的 TSP4 在 TG 或 Vc/C2 中的表达将分别用于识别 TSP4 在慢性疼痛处理中的作用位点。我们将进行共聚焦和电子显微镜来确定神经损伤模型中异常突触发生的程度。此外,将使用相应的药物研究下行调节途径和电压门控钙通道对 TSP4 介导的行为超敏反应和背角神经元过度兴奋的影响。 TSP4 对感觉神经元兴奋性、钙通道活性和细胞内钙信号传导的影响将在来自神经损伤模型的分离神经元或完整 TG 中或在 TSP4 治疗后进行研究。为了确定 TSP4 是否通过其受体、钙通道 α-2-δ-1 亚基 (Cava2d1) 相互作用,以感觉神经元特异性方式诱导行为超敏反应和背角神经元过度兴奋,将使用在感觉神经元亚群中选择性删除 Cava2d1 的 Cava2d1 条件敲除小鼠进行这些研究。拟议研究的最终目标是确定三叉神经损伤后 TSP4 介导的慢性疼痛状态转变的周围和/或中枢机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZHIGANG David LUO其他文献

ZHIGANG David LUO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZHIGANG David LUO', 18)}}的其他基金

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
  • 批准号:
    10552492
  • 财政年份:
    2022
  • 资助金额:
    $ 12.38万
  • 项目类别:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
  • 批准号:
    10452913
  • 财政年份:
    2021
  • 资助金额:
    $ 12.38万
  • 项目类别:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
  • 批准号:
    10670457
  • 财政年份:
    2019
  • 资助金额:
    $ 12.38万
  • 项目类别:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
纳米颗粒介导体内细胞类型特异性药物递送以缓解疼痛
  • 批准号:
    8364809
  • 财政年份:
    2012
  • 资助金额:
    $ 12.38万
  • 项目类别:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
纳米颗粒介导体内细胞类型特异性药物递送以缓解疼痛
  • 批准号:
    8501694
  • 财政年份:
    2012
  • 资助金额:
    $ 12.38万
  • 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
  • 批准号:
    8101208
  • 财政年份:
    2011
  • 资助金额:
    $ 12.38万
  • 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
  • 批准号:
    8254372
  • 财政年份:
    2011
  • 资助金额:
    $ 12.38万
  • 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
  • 批准号:
    8420544
  • 财政年份:
    2011
  • 资助金额:
    $ 12.38万
  • 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面神经病理性疼痛发展的新途径
  • 批准号:
    8804851
  • 财政年份:
    2011
  • 资助金额:
    $ 12.38万
  • 项目类别:
A novel pathway mediating the development of chronic orofacial neuropathic pain
介导慢性口面部神经病理性疼痛发展的新途径
  • 批准号:
    8617090
  • 财政年份:
    2011
  • 资助金额:
    $ 12.38万
  • 项目类别:

相似海外基金

Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
  • 批准号:
    RGPIN-2014-06641
  • 财政年份:
    2018
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
  • 批准号:
    RGPIN-2014-06641
  • 财政年份:
    2017
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
  • 批准号:
    RGPIN-2014-06641
  • 财政年份:
    2016
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Discovery Grants Program - Individual
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
  • 批准号:
    RGPIN-2014-06641
  • 财政年份:
    2015
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Discovery Grants Program - Individual
Development of a new pharmacotherapy for heart failure using alpha-2 adrenergic agonists
使用 α-2 肾上腺素能激动剂开发治疗心力衰竭的新药物疗法
  • 批准号:
    15K09110
  • 财政年份:
    2015
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Alteration of collagen synthesis and cross-link profile by beta-adrenergic agonists
β-肾上腺素能激动剂改变胶原合成和交联特征
  • 批准号:
    RGPIN-2014-06641
  • 财政年份:
    2014
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Discovery Grants Program - Individual
Reversing oxidative inhibition of the Na-K pump by beta3 adrenergic agonists: implications for heart failure therapy
β3 肾上腺素能激动剂逆转 Na-K 泵的氧化抑制:对心力衰竭治疗的影响
  • 批准号:
    nhmrc : 633252
  • 财政年份:
    2010
  • 资助金额:
    $ 12.38万
  • 项目类别:
    NHMRC Project Grants
Research of the molecular mechanism in effects of doping drugs(adrenergic agonists)
兴奋剂药物(肾上腺素激动剂)作用的分子机制研究
  • 批准号:
    21500628
  • 财政年份:
    2009
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EFFECTS OF ALPHA2-ADRENERGIC AGONISTS AND NMDA-ANTAGONISTS ON CEREBRAL MICROCIRCULATION UNDER THE HYPOTHERMIC CONDITION -ASSESSED WITH CLOSED CRANIAL WINDOW TECHNIQUE-.
α2-肾上腺素能激动剂和 NMDA 拮抗剂对低温条件下脑微循环的影响 - 用闭颅窗技术评估 -。
  • 批准号:
    11671489
  • 财政年份:
    1999
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EFFECTS OF NMDA-ATAGONISTS AND ALPHA2-ADRENERGIC AGONISTS ON SPINAL AND CEREBRAL MICROCIRCULATION -ASSESSED WITH CLOSED SPINAL AND CRANIAL WINDOW TECHNIQUE-.
NMDA 激动剂和 α2 肾上腺素能激动剂对脊髓和大脑微循环的影响 - 使用闭合脊柱和颅窗技术进行评估 -。
  • 批准号:
    09671555
  • 财政年份:
    1997
  • 资助金额:
    $ 12.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了